Mokari Atabak bought CORT
July 30, 2026 · Form 4 insider transaction
Mokari Atabak bought 80,000 shares of Corcept Therapeutics Incorporated at $23.06 per share, a transaction worth $1.84M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.